CANCER Versus TAX

More than 5,000 cancer patients will be denied life-extending drugs under plans which charities say are a “dreadful” step backwards for the NHS.


Health officials have just announced sweeping restrictions on treatment, which will mean patients with breast, bowel, skin and pancreatic cancer will no longer be able to receive drugs funded by the NHS.


In total, 17 cancer drugs for 25 different indications will no longer be paid for in future.

Patients affected

• Blood cancer - 1,759 patients
• Breast cancer - 986 patients
• Bowel cancer - 845 patients
• Prostate cancer - 601 patients
• Upper gastrointestinal cancer - 549 patients
• Urological cancer - 376 patients
• Brain and central nervous system - 229 patients
• Gynaecological cancer - 188 patients.

Charities said the direction the health service was heading in could set progress back by centuries.


The Cancer Drugs Fund was launched in 2011, following a manifesto pledge by David Cameron, who said patients should no longer be denied drugs on cost grounds.

We have also uncovered a £9billion black hole in UK corporation tax, helped by new rules brought in by George Osborne.

Six of the world’s biggest companies paid just 0.3 per cent of their UK earnings in corporation tax last year, a Sunday Mirror probe has found. (2015)

Amazon, which had sales in the UK of £3.35bn in 2011, only reported a "tax expense" of £1.8m.

And Google's UK unit paid just £6m to the Treasury in 2011 on UK turnover of £395m.

To: David Cameron

We wish you to change the decision to cut vital Cancer drugs for the following patients groups.

You could do this by stopping the tax avoidance from multi national companies operating in the UK or get them to stump up the needed cash.